Zheng Sun
Tracked across 1 events · 6 articles · First seen Jun 05, 2026 · Last active Jun 24, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Dr. Zheng Sun is the corresponding author of the study, leading the research that challenges the traditional understanding of HDAC inhibitors and proposing new avenues for cancer treatment.
Jun 05, 2026 · 6 articles
85
Zheng Sun proposed new mechanismBaylor Challenges HDAC...
ERGEN INTELLIGENCE
Track Zheng Sun live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard